Science Explorer Back to mapMap
Discussion
Company · Bromma · Sweden

Atlas Antibodies (Sweden)

Research works
6
▼ 62% vs 2018-21
Citations
196
30.4 per fractional work
Top-10% rate
0.0%
all institutions 10.0%
Open access
76%
world 40%
International
41%
world 18%

Not ranked overall: Atlas Antibodies (Sweden) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Atlas Antibodies (Sweden) work in?

In all years, 54% of research at Atlas Antibodies (Sweden) is in Life Sciences, 37% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (52%), Medicine (37%), Chemistry (9%). It does 1.6× the world's share of Life Sciences.

Life Sciences: 3 fractional works · 53.6% of its workBiochemistry, Genetics and Molecular Biology: 3 fractional works · 51.6% of its workMolecular Biology: 3 fractional works · 46.0% of its workGenetics: 0 fractional works · 3.0% of its workCancer Research: 0 fractional works · 1.9% of its workBiotechnology: 0 fractional works · 0.9% of its workNeuroscience: 0 fractional works · 2.0% of its workCellular and Molecular Neuroscience: 0 fractional works · 2.0% of its workHealth Sciences: 2 fractional works · 37.1% of its workMedicine: 2 fractional works · 37.1% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 16.0% of its workSurgery: 0 fractional works · 6.2% of its workOncology: 0 fractional works · 4.8% of its workPathology and Forensic Medicine: 0 fractional works · 2.2% of its workPharmacology: 0 fractional works · 1.9% of its workNephrology: 0 fractional works · 1.6% of its workPulmonary and Respiratory Medicine: 0 fractional works · 1.2% of its workGastroenterology: 0 fractional works · 0.9% of its workEpidemiology: 0 fractional works · 0.6% of its workPhysiology: 0 fractional works · 0.6% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.6% of its workRheumatology: 0 fractional works · 0.6% of its workPhysical Sciences: 1 fractional works · 9.3% of its workChemistry: 1 fractional works · 9.3% of its workSpectroscopy: 1 fractional works · 8.7% of its workOrganic Chemistry: 0 fractional works · 0.6% of its workALL ITS WORKAtlas Antibodies(Sweden)6fractional works, all years
Life Sciences54%Physical Sciences9%Health Sciences37%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 4 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology351.6%
    2. Neuroscience02.0%
    1. Medicine237.1%
    1. Chemistry19.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from Atlas Antibodies (Sweden)?

The most cited paper from Atlas Antibodies (Sweden) is "Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial" (Olöf Bjarnadottir, Quinci Romero, Pär‐Ola Bendahl et al., 2013), with 236 citations. Next come "The Role of SATB2 as a Diagnostic Marker for Tumors of Colorectal Origin" (139) and "Tumor Targeting Using Affibody Molecules: Interplay of Affinity, Target Expression Level, and Binding Site Composition" (96).

Most cited papers
#PaperReleasedCitations
1 Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial Olöf Bjarnadottir, Quinci Romero, Pär‐Ola Bendahl et al. · Breast Cancer Research and Treatment 7 Mar 2013 236
2 The Role of SATB2 as a Diagnostic Marker for Tumors of Colorectal Origin Anca D. Dragomir, Meike de Wit, Christine Johansson et al. · American Journal of Clinical Pathology 8 Apr 2014 139
3 Tumor Targeting Using Affibody Molecules: Interplay of Affinity, Target Expression Level, and Binding Site Composition Vladimir Tolmachev, Thuy Tran, Daniel Rosik et al. · Journal of Nuclear Medicine Open access 14 May 2012 96
4 Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer Karolina Boman, Anna Larsson, Ulrika Segersten et al. · British Journal of Cancer Open access 7 May 2013 75
5 HMG‐CoA reductase expression in breast cancer is associated with a less aggressive phenotype and influenced by anthropometric factors Signe Borgquist, Soraya Djerbi, Fredrik Pontén et al. · International Journal of Cancer 4 Jun 2008 65
All 29 most cited papers, with filters and sorting

Which research topics does Atlas Antibodies (Sweden) publish most on?

By volume in 2022-now: Protein Structure and Dynamics, Protein Degradation and Inhibitors, Bioinformatics and Genomic Networks and Radiopharmaceutical Chemistry and Applications.

  1. 1 Protein Structure and Dynamics Molecular Biology 0 works
  2. 2 Protein Degradation and Inhibitors Molecular Biology 0 works
  3. 3 Bioinformatics and Genomic Networks Molecular Biology 0 works
  4. 4 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 0 works
  5. 5 Lung Cancer Research Studies Oncology 0 works
  6. 6 Neuroendocrine Tumor Research Advances Epidemiology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available75.6%not open24.4%

World: 40% of research is openly available.

with international co-authors40.7%domestic only59.3%

World: 18% is written across borders.

How has Atlas Antibodies (Sweden)'s research output changed?

Output in 2022-2025 was 62% lower than in 2018-2021.

201020152020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Atlas Antibodies (Sweden) as a percentage of every work published that year, 0.0000049% in 2021.

0.000025%0.000050%0.000075%Atlas Antibodies (Sweden)0.0000056% in 202220102020

Fractional works of Atlas Antibodies (Sweden) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Bromma

All research institutions in Bromma

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Atlas Antibodies (Sweden). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.